Observational data to study medication outcomes in systemic sclerosis
J Rheumatol
.
2011 Mar;38(3):575-7.
doi: 10.3899/jrheum.100386.
Authors
Marie Hudson
,
Murray Baron
;
Canadian Scleroderma Research Group (CSRG)
;
Russell Steele
Collaborators
Canadian Scleroderma Research Group (CSRG)
:
M Baron
,
J Pope
,
J Markland
,
D Robinson
,
N Jones
,
N Khalidi
,
P Docherty
,
E Kaminska
,
A Masetto
,
D Smith
,
E Sutton
,
J -P Mathieu
,
M Hudson
,
S Ligier
,
T Grodzicky
,
S Mittoo
,
M Fritzler
PMID:
21362793
DOI:
10.3899/jrheum.100386
No abstract available
Publication types
Comment
Letter
MeSH terms
Female
Humans
Immunosuppressive Agents / therapeutic use*
Placebos
Randomized Controlled Trials as Topic
Scleroderma, Systemic / drug therapy*
Treatment Outcome*
Substances
Immunosuppressive Agents
Placebos